About iXensoriXensor is a health technology company that integrates medical engineering, biochemistry, and information technology expertise to develop the PixoTech® platform for connected smart healthcare. Based on the mentioned above, iXensor created PixoTest®, the world first FDA approved smartphone camera-based blood test system for healthcare in 2017.
iXensor's innovative PixoTech® platform, a smart color sensing technology for connected healthcare, allows them to develop a wide range of professional in-vitro diagnostics (IVD) medical devices and OTC self-test products.
In 2020, acceptance of TeleHealth has been accelerated by the COVID-19 pandemic. iXensor aims to support organizations in preventing outbreak with the fully integrated PixoTest COVID-19 Antigen Test and PixoHealth Pass App.
iXensor received several international awards, including the 2014 MEDICA eHealth Innovation Award, 2017 Digital Health Award, 2017 Japan Good Design, 2018 CES Best BabyTech Award, and 2019 German Design Award.
NAPPA Award 2020
German Design Award 2019
Taiwan Excellence 2018
Digital Health Awards Spring 2017
Good Design 2017
National Innovation Award
Taipei Biotech Award
Nokia Open Innovation Challenge 2016
Medical eHealth Innovation Award (Medica)
COVID-19 Antigen Testing
The fastest COVID-19 antigen test for smarter pandemic managementThe PixoTest® POCT COVID-19 Antigen Testing is a smart antigen testing solution — issuing test results to PixoHealth Pass App users — designed as a new aid to managing the COVID-19 outbreak for corporations and healthcare facilities.
Transform Rapid Testing Paradigm
Features and Benefits
Fast and accurate resultsDetect positive cases in 5-15 minutes.
Objective, standardized analysisReduce human error. Streamline workflow.
Encrypted digital health passEnable smarter pandemic management.
PixoTest® COVID-19 Ag Test
For use with PixoTest® POCT AnalyzerThe PixoTest® COVID-19 Ag Test is a rapid immuno-chromatographic assay for the qualitative detection of SARS-CoV-2 present in human nasopharynx. The PixoTest® COVID-19 Ag Test, together with PixoTest® POCT Analyzer (Model No. POC-X02), accommodates a wide range of workflows with its two test modes. In the Read Now mode, the analyzer yields test results within 30 seconds. The Walk Away mode offers automated timing and qualitative results in as short as 5 minutes for the positive results and up to 15 minutes for the negative cases.
|Time to result||5 - 15 minutes|
|Sample type||Direct nasopharyngeal swabs|
|Kit storage conditions||2°C to 30°C / 36°F to 86°F|
|Operating temperature||15°C to 30°C / 59°F to 86°F|
|Limit of detection||125 TCID50/mL|
PixoTest Covid-19 Antigen Test System Rapid ResultThe PixoTest® COVID-19 Antigen Test, together with the PixoTest® POCT Analyzer, can yield positive results in as short as 5 minutes through computer-aided analysis, minimizing the chances of misinterpretation by human eyes.
PixoHealth Pass App
Faster reporting process helps to control outbreaks more efficientlyLab testing can take up to one week to issue the test report. iXensor disrupts the conventional test reporting workflow by combining the use of both PixoTest® COVID-19 Antigen Test System and the PixoHealth Pass App.
The PixoHealth Pass App displays the test result on the Testers’ mobile phone simultaneously as soon as the hand-held size PixoTest® POCT Analyzer finishes analysis. The entirely digitalized journey shortens the long wait from testing to receiving a report to around 15 minutes.
Download the PixoHealth Pass AppIn countries with the marketing approval of the PixoTest® COVID-19 Ag Test, the PixoHealth Pass App will be available at no cost from the App Store and the Google Play store for all testees. PixoHealth Pass App will generate a unique and encrypted ID QR code for each testee upon the completion of registration.
Scan the PixoHealth Pass ID QR codePrior to conducting the PixoTest® POCT COVID-19 Ag Test at any “PixoHealth Pass-enabled” testing sites, the trained professionals need to scan testee’s unique ID QR code via PixoTest® POCT Analyzer. Once the testing is done, the PixoTest® POCT Analyzer will transmit test result seamlessly to PixoHealth Pass App users.
Benefits for organizations to deploy PixoHealth PassThe PixoHealth Pass App will issue a “result QR code” as the digital health pass if the result is negative. It helps to ease the overwhelming demand for rapid screening in the flu season, during which the rapid distinction in between COVID-19 and flu is critical for medical triage and sustaining a safe environment.
PixoHealth Pass Admin App
Lower total cost of screening, higher effectiveness of COVID-19 managementPixoHealth Pass Admin App, will empower organizations and event organizers to better manage the risk of becoming a COVID-19 cluster. The PixoHealth Pass Admin functions as a virtual gatekeeper that validates each test result shown by PixoHealth Pass users via a quick scan of the QR code.
Event organizers, schools,ports manufacturers, military and the hospitality industry are all likely to sustain their operations by adopting iXensor’s cost-effective solution that enables frequent testing without the costly PCR test.
1. What is the key advantage of the PixoTest COVID-19 antigen testing compared to other rapid antigen tests?
The PixoTest COVID-19 antigen testing, which offers computer-aided analysis of test results on the PixoTest POCT analyzer, reduces the chance of misinterpretation of the test results significantly. The majority of rapid antigen tests are read with the naked eye, resulting in increasing the risk of false negatives.
2. How reliable is the PixoTest COVID-19 antigen testing?
The analytical performance of PixoTest COVID-19 antigen testing is proven to be equally superior as the leading multinational IVD brands' rapid antigen tests with a limit of detection of 125 TCID50/mL.
3. What are the suitable use cases of the PixoTest COVID-19 antigen testing?
The PixoTest COVID-19 antigen testing can be used in any setting where frequent screening of COVID-19 infection is essential to maintain a safe environment. For instance, the schools, corporations from the airline industry and international trade, warehouses and manufacturing sites are the key areas of application, as long as the test is performed by the healthcare professionals. In the scenarios where timely screening of COVID-19 infected suspects is critical, such as visitors and participants of events, large gatherings and business meetings, the PixoTest COVID-19 antigen testing is the practical and dependable solution.
4. What's the benefit of using the PixoHealth Pass?
The PixoHealth Pass App will be available at no cost from the App Store and the Google Play store. Due to the existing manual reporting practices from many of the lab testing providers, testees can only receive the test report in 1-3 days. With the PixoHealth Pass App installed on the smartphones, the testees will receive the test result seamlessly and simultaneously on the app as soon as the test is analyzed. The result page on the PixoHealth Pass displays essential and encrypted information for PixoHealth Pass users to demonstrate their health conditions with evidence and convenience.
5. How can my organization adopt PixoHealth Pass for points of entry surveillance?
Together with PixoHealth Pass App, iXensor will provide organizations with PixoHealth Pass Admin App as the tool to validate the authenticity of PixoTest®COVID-19 Ag test results shown by PixoHealth Pass App users efficiently.
The PixoHealth Pass Admin App works solely as a processing tool, which validates test records generated from PixoTest® POCT Analyzer and stored on the cloud via a quick scan of PixoHealth Pass QR code. In addition, the PixoHealth Pass Admin App gives the autonomy of each organization to set the validity of the test result – the flexibility of adjusting the strictness of access control such as the maximal acceptable duration of the lastest test results. iXensor will provide the access for side-loading this administrator app, please contact us.